ACCC Launches New Public Policy Website

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 1
Volume 11
Issue 1

ROCKVILLE, Maryland-The Association of Community Cancer Centers (ACCC) has launched a new website (www.accc-cancer.org/publicpolicy) dedicated to regulatory and legislative issues affecting patients with cancer. The website will assist in the education of patients and their families about public policy that affects cancer care.

ROCKVILLE, Maryland—The Association of Community Cancer Centers (ACCC) has launched a new website (www.accc-cancer.org/publicpolicy) dedicated to regulatory and legislative issues affecting patients with cancer. The website will assist in the education of patients and their families about public policy that affects cancer care.

The new website also was designed to serve as a tool to bring patients and physicians together to discuss important cancer issues, such as new therapeutic modalities, insurance reimbursement, and clinical trials. The public policy site features information for patients and their families regarding access to cancer care, and details on oral cancer drugs and the congressional actions affecting use of such drugs.

The site features a section on legislative alerts, general information about Capitol Hill legislators, and tips for patients with cancer and their families on communicating with their representatives. The site also provides a directory of ACCC member hospitals and physicians, a list of patient advocacy organizations, and contact information for representatives and senators.

"By providing patients and families with information about the public policies that impact cancer care and helping them learn about the legislative process, they will be able to fully act on their rights and enlist the government in their personal battles against cancer," said Margaret A. Riley, MN, RN, of ACCC’s Ad Hoc Committee for Advocacy. 

Recent Videos
Analysis of 2 phase 1 trials compared gut biome diversity between standard of care with or without CBM588 in patients with metastatic renal cell carcinoma.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
4 KOLs are featured in this panel.
4 KOLs are featured in this panel.
Isabel Preeshagul, DO, MBS, with the Oncology Brothers presenting slides
Isabel Preeshagul, DO, MBS, with the Oncology Brothers presenting slides
Isabel Preeshagul, DO, MBS, with the Oncology Brothers presenting slides
Isabel Preeshagul, DO, MBS, with the Oncology Brothers presenting slides
2 KOLs are featured in this series
Related Content